Ethypharm (Omeprazole and Ketoprofen products) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Ethypharm (Omeprazole and Ketoprofen products) General Information

Description

A portfolio of gastrointestinal problems treating product line. The product line consists of omeprazole (proton pump inhibitor) and ketoprofen (nonsteroidal anti-inflammatory drug) that come in the form of a capsule and offers protection against nonsteroidal anti-inflammatory drug's side effects and mucosal injuries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 194, Bureaux de la Colline
  • 92213 Saint-Cloud
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ethypharm (Omeprazole and Ketoprofen products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ethypharm (Omeprazole and Ketoprofen products)‘s full profile, request access.

Request a free trial